Science Applications International Corporation reported second-quarter fiscal 2027 revenue of $1.88 billion, up 6.3% year over year, but net bookings of approximately $1.2 billion produced a quarterly book-to-bill ratio of 0.6, with a trailing 12-month ratio of 0.8. Total backlog stood at approximately $22.1 billion, including $3.8 billion of funded backlog and $18.3 billion of negotiated unfunded backlog, down from $22.6 billion at the end of fiscal 2026. The company's non-GAAP organic revenue growth was 5.3%, and management raised fiscal 2027 revenue guidance to $7.2 billion to $7.3 billion from $7.0 billion to $7.2 billion. Operating cash flow rose 20% to $146 million, but adjusted diluted EPS fell 17% to $3.01, partly due to a prior-year tax benefit, and adjusted free cash flow declined 13% to $131 million. A subsequent five-year, approximately $740 million recompete award from the U.S. Department of Homeland Security is expected to strengthen next quarter's bookings, though the backlog remains mostly unfunded and the book-to-bill ratio below one.
Science Applications International Corporation Common StockBook-to-bill ratio fell to 0.6, indicating weak demand for new contracts despite revenue growth.
Chevron Corp